L29223-LCD

LCD/NCD Portal

Automated World Health

Local Coverage Determination (LCD) for Magnetic Resonance Imaging of Upper Extremity (L29223)

The Limitations section of the LCD has been revised to update language surrounding the coverage of MRI in patients with implantable pacemakers. CMS issued new language in the NCD for Pacemakers through Change Request 7441, transmittals 134 and 2293. These revisions are effective for claims processed on or after September 26, 2011 for dates of service on or after July 7, 2011.

Contractor Information

Contractor Name

First Coast Service Options, Inc. opens in new window

Contractor Number

09102

Contractor Type

MAC - Part B

LCD Information

Document Information

LCD ID Number L29223

LCD Title

Magnetic Resonance Imaging of Upper Extremity

Contractor's Determination Number 73218

Primary Geographic Jurisdiction opens in new window

Florida

Oversight Region Region IV

AMA CPT/ADA CDT Copyright Statement

CPT only copyright 2002-2011 American Medical Association. All Rights Reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. The Code on Dental Procedures and Nomenclature (Code) is published in Current Dental Terminology (CDT). Copyright © American Dental Association. All rights reserved. CDT and CDT-2010 are trademarks of the American Dental Association.

Original Determination Effective Date

For services performed on or after 02/02/2009

Original Determination Ending Date

Revision Effective Date

For services performed on or after 10/01/2011

Revision Ending Date

CMS National Coverage Policy

Language quoted from CMS National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals are italicized throughout the Local Coverage Determination (LCD). NCDs and coverage provisions in interpretive manuals are not subject to the LCD Review Process (42 CFR 405.860[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See § 1869 (f)(1)(A)(i) of the Social Security Act.

Unless other wise specified, italicized text represents quotation from one or more of the following CMS sources: CMS Manual System, Pub 100-3,Medicare National Coverage Determinations Chapter 1, Part 3, Section 220.2

CMS Manual System, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 80.6 - 80.6.4

Change Request 7296, Transmittals 132 and 2171, dated March 4, 2011

Change Request 7441, Transmittals 134 and 2293, dated August 26, 2011

Indications and Limitations of Coverage and/or Medical Necessity

Magnetic Resonance Imaging (MRI) is a non-invasive imaging technique used for a variety of diagnostic visualizations. Unlike computed tomography (CT) scanning, MRI does not make use of ionizing radiation or require iodinated contrast material to distinguish normal from pathologic tissue. Rather, the process employs the magnetic properties of the hydrogen nucleus (proton) and its interaction with strong external magnetic fields and radio frequency pulses. The patient is placed in a strong magnetic field and radio frequency pulses are transmitted into the patient in an extremely controlled and defined manner. The protons within the patient will subsequently emit a radio frequency signal, which is processed by a computer to produce an image.

MRI provides superior tissue contrast when compared to CT, is able to image in multiple planes, is not affected by bone artifact, provides vascular imaging capability, and makes use of safer contrast media. Its major disadvantages over CT include longer scanning times, which make MRI less useful in emergency evaluations. The use of MRI on certain soft tissue structures for the purpose of detecting disruptive, neoplastic, degenerative, or inflammatory lesions has now become established in medical practice.

Medicare will consider MRI of the upper extremity CPT codes (73218-73223) medically reasonable and necessary under the following conditions:

Indications:

Soft Tissues

• Evaluating soft tissue masses and subtle bone injuries.

• Evaluation of traumatic muscle and tendon injuries, hematomas, compartment syndromes, entrapment syndromes, tendinosis, tenosynovitis, and bursitis.

• Evaluation of infections, abscesses and myositis.

• Evaluation of masses such as simple non-neoplastic cysts, abscesses, ganglion cysts, paramensical cysts, hematomas, muscle tears, and ligament and tendon tears.

• Detection, staging, and characterization of benign and malignant soft tissue neoplasms and for the follow-up evaluation of neoplastic disease and therapy.

Bones

• In trauma, for the evaluation of suspected x-ray occult injuries of the metaphysis and epiphysis and to assess fracture union.

• To detect and size acute and chronic osteomyelitis and to evaluate perioprosthetic infections in selected cases.

• To detect and stage primary bone tumors, both non-neoplastic and neoplastic (Please also consider whether follow-up for local recurrence of bone tumor should also be included).

• To detect and stage occult bony metastases.

Joints – Diseases affecting all joints. MRI can be used to evaluate the following:

• Pain or loss of function of undetermined etiology.

• Joint instability and internal derangement.

• Selected articular cartilage injuries.

• Degenerated joint disease.

• Traumatic injuries to joints and adjacent muscles, tendons, and ligaments

• Articular cartilage injuries

• Bursitis and synovitis from overuse, fragment stability and cartilage status in osteochondritis dissecans

• Posttraumatic osteonecrosis and degenerative joint disease

• Loose bodies, and tenosynovitis

• Joint infections (noninfectious inflammatory joint disease such as rheumatoid and the seronegative arthritis, overuse synovitis, tenosynovitis, and tendonopathy)

• Ganglion cysts, bursal cysts with bursitis, abscesses, benign neoplastic masses, and primary and metastatic masses

• Osteonecrosis including avascular necrosis, and degenerative joint disease

Elbow Joints MRI can be used in the evaluation of:

• Medical epicondylitis (tennis elbow)

• Fractures in children

• Osteochondral defects, and osteonecrosis

• Evaluation of suspected collateral ligament teat and suspected biceps tendon teat and/or bursitis

Wrist, Hand, and Fingers MRI can be used in the detection and evaluation of:

• Carpal tunnel syndrome

• Tendon and ligamentous injuries

• Triangular fibrocartilage injuries

• Extensor and flexor tenosynovitis

• De Quervain’s syndrome

• Keinbach’s disease

• Injuries of the flexor and extensor tendons

• Tenosynovitis and masses

Limitations of Coverage

1. Contraindications

The MRI is not covered when the following patient-specific contraindications are present:

• MRI is not covered for patients with cardiac pacemakers or with metallic clips on vascular aneurysms unless the Medicare beneficiary meets the provisions of the following exceptions:

Effective for claims with dates of service on or after July 7, 2011, the contraindications will not apply to pacemakers when used according to the FDA-approved labeling in an MRI environment, or effective for claims with dates of service on or after February 24, 2011, CMS believes that the evidence is promising although not yet convincing that MRI will improve patient health outcomes if certain safeguards are in place to ensure that the exposure of the device to an MRI environment adversely affects neither the interpretation of the MRI result nor the proper functioning of the implanted device itself. We believe that specific precautions (as listed below) could maximize benefits of MRI exposure for beneficiaries enrolled in clinical trials designed to assess the utility and safety of MRI exposure. Therefore, CMS determines that MRI will be covered by Medicare when provided in a clinical study under section 1862(a)(1)(E) (consistent with section 1142 of the Act) through the Coverage with Study Participation (CSP) form of Coverage with Evidence Development (CED) if the study meets the criteria in each of the three paragraphs in CMS Pub 100-03, CMS National Coverage Determination Manual, Chapter 1, Section 220.2.C.1.

• MRI during a viable pregnancy is also contraindicated at this time. The danger inherent in bringing ferromagnetic materials within range of MRI units generally constrains the use of MRI on acutely ill patients requiring life support systems and monitoring devices that employ ferromagnetic materials.

• In addition, the long imaging time and the enclosed position of the patient may result in claustrophobia, making patients who have a history of claustrophobia unsuitable candidates for MRI procedures.

2. Nationally Noncovered Indications

The CMS has determined that MRI of cortical bone and calcifications, and procedures involving spatial resolution of bone and calcifications, are not considered reasonable and necessary indications within the meaning of section 1862(a)(1)(A) of the Social Security Act, and are therefore noncovered.

Coverage is limited to MRI units that have FDA premarket approval, and such units must be operated within the parameters specified by the approval. In addition, the services must be reasonable and necessary for the diagnosis or treatment of the specific patient involved.

Coding Information

Bill Type Codes:

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

Revenue Codes:

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes.

99999 Not Applicable

CPT/HCPCS Codes

73218 MAGNETIC RESONANCE (EG, PROTON) IMAGING, UPPER EXTREMITY, OTHER THAN JOINT; WITHOUT CONTRAST MATERIAL(S)

73219 MAGNETIC RESONANCE (EG, PROTON) IMAGING, UPPER EXTREMITY, OTHER THAN JOINT; WITH CONTRAST MATERIAL(S)

73220 MAGNETIC RESONANCE (EG, PROTON) IMAGING, UPPER EXTREMITY, OTHER THAN JOINT; WITHOUT CONTRAST MATERIAL(S), FOLLOWED BY CONTRAST MATERIAL(S) AND FURTHER SEQUENCES

73221 MAGNETIC RESONANCE (EG, PROTON) IMAGING, ANY JOINT OF UPPER EXTREMITY; WITHOUT CONTRAST MATERIAL(S)

73222 MAGNETIC RESONANCE (EG, PROTON) IMAGING, ANY JOINT OF UPPER EXTREMITY; WITH CONTRAST MATERIAL(S)

73223 MAGNETIC RESONANCE (EG, PROTON) IMAGING, ANY JOINT OF UPPER EXTREMITY; WITHOUT CONTRAST MATERIAL(S), FOLLOWED BY CONTRAST MATERIAL(S) AND FURTHER SEQUENCES

ICD-9 Codes that Support Medical Necessity

003.24 SALMONELLA OSTEOMYELITIS

115.10 -

115.19 opens in new window

INFECTION BY HISTOPLASMA DUBOISII WITHOUT MANIFESTATION - INFECTION BY

HISTOPLASMA DUBOISII WITH OTHER MANIFESTATION

170.4 MALIGNANT NEOPLASM OF SCAPULA AND LONG BONES OF UPPER LIMB

170.5 MALIGNANT NEOPLASM OF SHORT BONES OF UPPER LIMB

170.9 MALIGNANT NEOPLASM OF BONE AND ARTICULAR CARTILAGE SITE UNSPECIFIED

171.0 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF HEAD FACE AND NECK

171.2 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF UPPER LIMB INCLUDING SHOULDER

171.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF CONNECTIVE AND OTHER SOFT TISSUE

172.6 MALIGNANT MELANOMA OF SKIN OF UPPER LIMB INCLUDING SHOULDER

173.60 -

173.69 opens in new window

UNSPECIFIED MALIGNANT NEOPLASM OF SKIN OF UPPER LIMB, INCLUDING SHOULDER - OTHER SPECIFIED MALIGNANT NEOPLASM OF SKIN OF UPPER LIMB, INCLUDING SHOULDER

194.6 MALIGNANT NEOPLASM OF AORTIC BODY AND OTHER PARAGANGLIA

195.4 MALIGNANT NEOPLASM OF UPPER LIMB

196.3 SECONDARY AND UNSPECIFIED MALIGNANT NEOPLASM OF LYMPH NODES OF AXILLA AND UPPER LIMB

196.8 SECONDARY AND UNSPECIFIED MALIGNANT NEOPLASM OF LYMPH NODES OF MULTIPLE SITES

196.9 SECONDARY AND UNSPECIFIED MALIGNANT NEOPLASM OF LYMPH NODES SITE UNSPECIFIED

198.5 SECONDARY MALIGNANT NEOPLASM OF BONE AND BONE MARROW

198.89 SECONDARY MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES

200.00 -

200.88 opens in new window

201.00 -

201.98 opens in new window

202.00 -

202.98 opens in new window

203.00 -

203.82 opens in new window

RETICULOSARCOMA UNSPECIFIED SITE - OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES

HODGKIN'S PARAGRANULOMA UNSPECIFIED SITE - HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF MULTIPLE SITES

NODULAR LYMPHOMA UNSPECIFIED SITE - OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF MULTIPLE SITES

MULTIPLE MYELOMA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION - OTHER IMMUNOPROLIFERATIVE NEOPLASMS, IN RELAPSE

208.90 UNSPECIFIED LEUKEMIA, WITHOUT MENTION OF HAVING ACHIEVED REMISSION

208.92 UNSPECIFIED LEUKEMIA, IN RELAPSE

213.4 BENIGN NEOPLASM OF SCAPULA AND LONG BONES OF UPPER LIMB

213.5 BENIGN NEOPLASM OF SHORT BONES OF UPPER LIMB

213.9 BENIGN NEOPLASM OF BONE AND ARTICULAR CARTILAGE SITE UNSPECIFIED

215.2 OTHER BENIGN NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF UPPER LIMB INCLUDING SHOULDER

215.8 OTHER BENIGN NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF OTHER SPECIFIED SITES

216.6 BENIGN NEOPLASM OF SKIN OF UPPER LIMB INCLUDING SHOULDER

227.6 BENIGN NEOPLASM OF AORTIC BODY AND OTHER PARAGANGLIA

228.1 LYMPHANGIOMA ANY SITE

232.6 CARCINOMA IN SITU OF SKIN OF UPPER LIMB INCLUDING SHOULDER

234.8 CARCINOMA IN SITU OF OTHER SPECIFIED SITES

237.3 NEOPLASM OF UNCERTAIN BEHAVIOR OF PARAGANGLIA NEUROFIBROMATOSIS UNSPECIFIED - OTHER NEUROFIBROMATOSIS

237.70 -

237.79 opens in new window

238.1 NEOPLASM OF UNCERTAIN BEHAVIOR OF BONE AND ARTICULAR CARTILAGE

238.2 NEOPLASM OF UNCERTAIN BEHAVIOR OF CONNECTIVE AND OTHER SOFT TISSUE

238.71 -

238.79 opens in new window

ESSENTIAL THROMBOCYTHEMIA - OTHER LYMPHATIC AND HEMATOPOIETIC TISSUES

239.2 NEOPLASM OF UNSPECIFIED NATURE OF BONE SOFT TISSUE AND SKIN

239.7 NEOPLASM OF UNSPECIFIED NATURE OF ENDOCRINE GLANDS AND OTHER PARTS OF NERVOUS SYSTEM

274.00 -

274.03 opens in new window

GOUTY ARTHROPATHY, UNSPECIFIED - CHRONIC GOUTY ARTHROPATHY WITH TOPHUS (TOPHI)

333.84 ORGANIC WRITERS' CRAMP

353.0 BRACHIAL PLEXUS LESIONS

354.0 - 354.9 opens

in new window CARPAL TUNNEL SYNDROME - MONONEURITIS OF UPPER LIMB UNSPECIFIED

359.21 -

359.29 opens in new window

MYOTONIC MUSCULAR DYSTROPHY - OTHER SPECIFIED MYOTONIC DISORDER

359.3 PERIODIC PARALYSIS

359.71 INCLUSION BODY MYOSITIS

442.0 - 442.9 opens

in new window ANEURYSM OF ARTERY OF UPPER EXTREMITY - OTHER ANEURYSM OF UNSPECIFIED SITE

444.21 ARTERIAL EMBOLISM AND THROMBOSIS OF UPPER EXTREMITY

444.9 EMBOLISM AND THROMBOSIS OF UNSPECIFIED ARTERY

447.0 ARTERIOVENOUS FISTULA ACQUIRED

447.70 -

447.73 opens in new window

AORTIC ECTASIA, UNSPECIFIED SITE - THORACOABDOMINAL AORTIC ECTASIA

457.1 POSTMASTECTOMY LYMPHEDEMA SYNDROME

457.2 OTHER LYMPHEDEMA

682.3 CELLULITIS AND ABSCESS OF UPPER ARM AND FOREARM

696.0 PSORIATIC ARTHROPATHY

711.1 PYOGENIC ARTHRITIS INVOLVING SHOULDER REGION

711.2 PYOGENIC ARTHRITIS INVOLVING UPPER ARM

711.3 PYOGENIC ARTHRITIS INVOLVING FOREARM

711.4 PYOGENIC ARTHRITIS INVOLVING HAND

711.41 -

711.47 opens in new window

711.61 -

711.67 opens in new window

711.91 -

711.97 opens in new window

ARTHROPATHY INVOLVING SHOULDER REGION ASSOCIATED WITH OTHER BACTERIAL DISEASES - ARTHROPATHY INVOLVING ANKLE AND FOOT ASSOCIATED WITH OTHER BACTERIAL DISEASE

ARTHROPATHY INVOLVING SHOULDER REGION ASSOCIATED WITH MYCOSES - ARTHROPATHY INVOLVING ANKLE AND FOOT ASSOCIATED WITH MYCOSES

UNSPECIFIED INFECTIVE ARTHRITIS INVOLVING SHOULDER REGION - UNSPECIFIED INFECTIVE ARTHRITIS INVOLVING ANKLE AND FOOT

714.0 RHEUMATOID ARTHRITIS

714.30 CHRONIC OR UNSPECIFIED POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS

714.31 ACUTE POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS

714.9 UNSPECIFIED INFLAMMATORY POLYARTHROPATHY

715.00 OSTEOARTHROSIS GENERALIZED INVOLVING UNSPECIFIED SITE

715.04 OSTEOARTHROSIS GENERALIZED INVOLVING HAND

715.09 OSTEOARTHROSIS GENERALIZED INVOLVING MULTIPLE SITES

715.11 -

715.14 opens in new window

OSTEOARTHROSIS LOCALIZED PRIMARY INVOLVING SHOULDER REGION -

OSTEOARTHROSIS LOCALIZED PRIMARY INVOLVING HAND

715.20 OSTEOARTHROSIS LOCALIZED SECONDARY INVOLVING UNSPECIFIED SITE

715.21 -

715.24 opens in new window

OSTEOARTHROSIS LOCALIZED SECONDARY INVOLVING SHOULDER REGION -

OSTEOARTHROSIS LOCALIZED SECONDARY INVOLVING HAND

715.30 OSTEOARTHROSIS LOCALIZED NOT SPECIFIED WHETHER PRIMARY OR SECONDARY INVOLVING UNSPECIFIED SITE

715.31 -

715.34 opens in new window

OSTEOARTHROSIS LOCALIZED NOT SPECIFIED WHETHER PRIMARY OR SECONDARY INVOLVING SHOULDER REGION - OSTEOARTHROSIS LOCALIZED NOT SPECIFIED WHETHER PRIMARY OR SECONDARY INVOLVING HAND

715.80 OSTEOARTHROSIS INVOLVING OR WITH MORE THAN ONE SITE BUT NOT SPECIFIED AS GENERALIZED AND INVOLVING UNSPECIFIED SITE

715.89 OSTEOARTHROSIS INVOLVING OR WITH MULTIPLE SITES BUT NOT SPECIFIED AS GENERALIZED

715.90 -

715.94 opens in new window

OSTEOARTHROSIS UNSPECIFIED WHETHER GENERALIZED OR LOCALIZED INVOLVING UNSPECIFIED SITE - OSTEOARTHROSIS UNSPECIFIED WHETHER GENERALIZED OR LOCALIZED INVOLVING HAND

715.98 OSTEOARTHROSIS UNSPECIFIED WHETHER GENERALIZED OR LOCALIZED INVOLVING OTHER SPECIFIED SITES

716.11 -

716.14 opens in new window

716.81 -

716.89 opens in new window

716.91 -

716.99 opens in new window

TRAUMATIC ARTHROPATHY INVOLVING SHOULDER REGION - TRAUMATIC ARTHROPATHY INVOLVING HAND

OTHER SPECIFIED ARTHROPATHY INVOLVING SHOULDER REGION - OTHER SPECIFIED ARTHROPATHY INVOLVING MULTIPLE SITES

UNSPECIFIED ARTHROPATHY INVOLVING SHOULDER REGION - UNSPECIFIED ARTHROPATHY INVOLVING MULTIPLE SITES

718.1 ARTICULAR CARTILAGE DISORDER SITE UNSPECIFIED

718.2 -

718.04 opens in new window

ARTICULAR CARTILAGE DISORDER INVOLVING SHOULDER REGION - ARTICULAR CARTILAGE DISORDER INVOLVING HAND

718.8 ARTICULAR CARTILAGE DISORDER INVOLVING OTHER SPECIFIED SITES

718.9 ARTICULAR CARTILAGE DISORDER INVOLVING MULTIPLE SITES

718.10 LOOSE BODY IN JOINT SITE UNSPECIFIED

718.11 -

718.14 opens in new window

LOOSE BODY IN JOINT OF SHOULDER REGION - LOOSE BODY IN HAND JOINT

718.18 LOOSE BODY IN JOINT OF OTHER SPECIFIED SITES

718.19 LOOSE BODY IN JOINT OF MULTIPLE SITES

718.20 -

718.24 opens in new window

PATHOLOGICAL DISLOCATION OF JOINT SITE UNSPECIFIED - PATHOLOGICAL

DISLOCATION OF HAND JOINT

718.29 PATHOLOGICAL DISLOCATION OF JOINT OF MULTIPLE SITES

718.30 -

718.34 opens in new window

RECURRENT DISLOCATION OF JOINT SITE UNSPECIFIED - RECURRENT DISLOCATION OF

HAND JOINT

718.39 RECURRENT DISLOCATION OF JOINT OF MULTIPLE SITES

718.40 -

718.44 opens in new window

CONTRACTURE OF JOINT SITE UNSPECIFIED - CONTRACTURE OF HAND JOINT

718.49 CONTRACTURE OF JOINT OF MULTIPLE SITES

718.50 -

718.54 opens in new window

ANKYLOSIS OF JOINT SITE UNSPECIFIED - ANKYLOSIS OF HAND JOINT

718.59 ANKYLOSIS OF JOINT OF MULTIPLE SITES

718.80 OTHER JOINT DERANGEMENT NOT ELSEWHERE CLASSIFIED INVOLVING UNSPECIFIED SITE

718.81 -

718.84 opens in new window

718.90 -

718.94 opens in new window

OTHER JOINT DERANGEMENT NOT ELSEWHERE CLASSIFIED INVOLVING SHOULDER REGION - OTHER JOINT DERANGEMENT NOT ELSEWHERE CLASSIFIED INVOLVING HAND

UNSPECIFIED DERANGEMENT OF JOINT SITE UNSPECIFIED - UNSPECIFIED DERANGEMENT OF HAND JOINT

718.98 UNSPECIFIED DERANGEMENT OF JOINT OF OTHER SPECIFIED SITES

719.1 EFFUSION OF JOINT OF SHOULDER REGION

719.2 EFFUSION OF UPPER ARM JOINT

719.3 EFFUSION OF FOREARM JOINT

Printed on 9/29/2012. Page 7 of 13

719.4 EFFUSION OF HAND JOINT

719.11 -

719.14 opens in new window

719.21 -

719.24 opens in new window

719.41 -

719.44 opens in new window

719.51 -

719.57 opens in new window

719.61 -

719.67 opens in new window

719.81 -

719.87 opens in new window

HERARTHROSIS INVOLVING SHOULDER REGION - HEMARTHROSIS INVOLVING HAND

VILLONODULAR SYNOVITIS INVOLVING SHOULDER REGION - VILLONODULAR SYNOVITIS INVOLVING HAND

PAIN IN JOINT INVOLVING SHOULDER REGION - PAIN IN JOINT INVOLVING HAND STIFFNESS OF JOINT NOT ELSEWHERE CLASSIFIED INVOLVING SHOULDER REGION -

STIFFNESS OF JOINT NOT ELSEWHERE CLASSIFIED INVOLVING ANKLE AND FOOT

OTHER SYMPTOMS REFERABLE TO JOINT OF SHOULDER REGION - OTHER SYMPTOMS REFERABLE TO ANKLE AND FOOT JOINT

OTHER SPECIFIED DISORDERS OF JOINT OF SHOULDER REGION - OTHER SPECIFIED DISORDERS OF ANKLE AND FOOT JOINT

726.0 ADHESIVE CAPSULITIS OF SHOULDER

726.10 -

726.19 opens in new window

DISORDERS OF BURSAE AND TENDONS IN SHOULDER REGION UNSPECIFIED - OTHER SPECIFIED DISORDERS OF BURSAE AND TENDONS IN SHOULDER REGION

726.2 OTHER AFFECTIONS OF SHOULDER REGION NOT ELSEWHERE CLASSIFIED

726.33 OLECRANON BURSITIS

726.4 ENTHESOPATHY OF WRIST AND CARPUS

727.00 SYNOVITIS AND TENOSYNOVITIS UNSPECIFIED

727.2 GIANT CELL TUMOR OF TENDON SHEATH

727.3 TRIGGER FINGER (ACQUIRED)

727.4 RADIAL STYLOID TENOSYNOVITIS

727.5 OTHER TENOSYNOVITIS OF HAND AND WRIST

727.40 SYNOVIAL CYST UNSPECIFIED

727.41 GANGLION OF JOINT

727.42 GANGLION OF TENDON SHEATH

727.51 SYNOVIAL CYST OF POPLITEAL SPACE

727.61 COMPLETE RUPTURE OF ROTATOR CUFF

727.62 NONTRAUMATIC RUPTURE OF TENDONS OF BICEPS (LONG HEAD)

727.63 NONTRAUMATIC RUPTURE OF EXTENSOR TENDONS OF HAND AND WRIST

727.64 NONTRAUMATIC RUPTURE OF FLEXOR TENDONS OF HAND AND WRIST

728.11 PROGRESSIVE MYOSITIS OSSIFICANS

728.12 TRAUMATIC MYOSITIS OSSIFICANS

728.19 OTHER MUSCULAR CALCIFICATION AND OSSIFICATION

728.86 NECROTIZING FASCIITIS

729.5 PAIN IN LIMB

729.71 NONTRAUMATIC COMPARTMENT SYNDROME OF UPPER EXTREMITY

730.01 -

730.04 opens in new window

ACUTE OSTEOMYELITIS INVOLVING SHOULDER REGION - ACUTE OSTEOMYELITIS

INVOLVING HAND

730.08 ACUTE OSTEOMYELITIS INVOLVING OTHER SPECIFIED SITES

730.11 -

730.14 opens in new window

CHRONIC OSTEOMYELITIS INVOLVING SHOULDER REGION - CHRONIC OSTEOMYELITIS

INVOLVING HAND

730.18 CHRONIC OSTEOMYELITIS INVOLVING OTHER SPECIFIED SITES

730.19 CHRONIC OSTEOMYELITIS INVOLVING MULTIPLE SITES

730.20 UNSPECIFIED OSTEOMYELITIS SITE UNSPECIFIED

730.21 -

730.24 opens in new window

730.91 -

730.94 opens in new window

UNSPECIFIED OSTEOMYELITIS INVOLVING SHOULDER REGION - UNSPECIFIED

OSTEOMYELITIS INVOLVING HAND

UNSPECIFIED INFECTION OF BONE OF SHOULDER REGION - UNSPECIFIED INFECTION OF HAND BONE

731.0 OSTEITIS DEFORMANS WITHOUT BONE TUMOR

732.3 JUVENILE OSTEOCHONDROSIS OF UPPER EXTREMITY

732.9 UNSPECIFIED OSTEOCHONDROPATHY

733.00 -

733.09 opens in new window

OSTEOPOROSIS UNSPECIFIED - OTHER OSTEOPOROSIS

733.11 PATHOLOGICAL FRACTURE OF HUMERUS

733.12 PATHOLOGICAL FRACTURE OF DISTAL RADIUS AND ULNA

733.20 -

733.29 opens in new window

733.40 -

733.49 opens in new window

CYST OF BONE (LOCALIZED) UNSPECIFIED - OTHER BONE CYST

ASEPTIC NECROSIS OF BONE SITE UNSPECIFIED - ASEPTIC NECROSIS OF OTHER BONE SITES

733.81 MALUNION OF FRACTURE

733.82 NONUNION OF FRACTURE

733.90 DISORDER OF BONE AND CARTILAGE UNSPECIFIED

747.63 UPPER LIMB VESSEL ANOMALY

755.20 -

755.29 opens in new window

755.50 -

755.59 opens in new window

UNSPECIFIED REDUCTION DEFORMITY OF UPPER LIMB CONGENITAL - LONGITUDINAL DEFICIENCY PHALANGES COMPLETE OR PARTIAL

UNSPECIFIED ANOMALY OF UPPER LIMB CONGENITAL - OTHER CONGENITAL ANOMALIES OF UPPER LIMB INCLUDING SHOULDER GIRDLE

782.0 DISTURBANCE OF SKIN SENSATION

785.6 ENLARGEMENT OF LYMPH NODES

793.7 NONSPECIFIC (ABNORMAL) FINDINGS ON RADIOLOGICAL AND OTHER EXAMINATION OF MUSCULOSKELETAL SYSTEM

795.4 OTHER NONSPECIFIC ABNORMAL HISTOLOGICAL FINDINGS

796.4 OTHER ABNORMAL CLINICAL FINDINGS

831.00 -

831.19 opens in new window

832.00 -

832.04 opens in new window

832.10 -

832.14 opens in new window

833.00 -

833.19 opens in new window

834.00 -

834.12 opens in new window

840.0 - 840.9 opens in new window 841.0 - 841.9 opens in new window

842.00 -

842.19 opens in new window

CLOSED DISLOCATION OF SHOULDER UNSPECIFIED SITE - OPEN DISLOCATION OF

OTHER SITE OF SHOULDER

CLOSED DISLOCATION OF ELBOW UNSPECIFIED SITE - CLOSED LATERAL DISLOCATION OF ELBOW

OPEN DISLOCATION OF ELBOW UNSPECIFIED SITE - OPEN LATERAL DISLOCATION OF ELBOW

CLOSED DISLOCATION OF WRIST UNSPECIFIED PART - OPEN DISLOCATION OF OTHER PART OF WRIST

CLOSED DISLOCATION OF FINGER UNSPECIFIED PART - OPEN DISLOCATION INTERPHALANGEAL (JOINT) HAND

ACROMIOCLAVICULAR (JOINT) (LIGAMENT) SPRAIN - SPRAIN OF UNSPECIFIED SITE OF SHOULDER AND UPPER ARM

RADIAL COLLATERAL LIGAMENT SPRAIN - SPRAIN OF UNSPECIFIED SITE OF ELBOW AND FOREARM

SPRAIN OF UNSPECIFIED SITE OF WRIST - OTHER HAND SPRAIN

905.8 LATE EFFECT OF TENDON INJURY

909.2 LATE EFFECT OF RADIATION

927.00 - 927.9 opens in new window

CRUSHING INJURY OF SHOULDER REGION - CRUSHING INJURY OF UNSPECIFIED SITE OF UPPER LIMB

958.91 TRAUMATIC COMPARTMENT SYNDROME OF UPPER EXTREMITY

959.2 OTHER AND UNSPECIFIED INJURY TO SHOULDER AND UPPER ARM

959.3 OTHER AND UNSPECIFIED INJURY TO ELBOW FOREARM AND WRIST

959.4 OTHER AND UNSPECIFIED INJURY TO HAND EXCEPT FINGER

959.5 OTHER AND UNSPECIFIED INJURY TO FINGER

996.1 MECHANICAL COMPLICATION OF OTHER VASCULAR DEVICE IMPLANT AND GRAFT

996.40 UNSPECIFIED MECHANICAL COMPLICATION OF INTERNAL ORTHOPEDIC DEVICE, IMPLANT, AND GRAFT

996.41 MECHANICAL LOOSENING OF PROSTHETIC JOINT

996.42 DISLOCATION OF PROSTHETIC JOINT

996.43 BROKEN PROSTHETIC JOINT IMPLANT

996.44 PERI-PROSTHETIC FRACTURE AROUND PROSTHETIC JOINT

996.45 PERI-PROSTHETIC OSTEOLYSIS

996.46 ARTICULAR BEARING SURFACE WEAR OF PROSTHETIC JOINT

996.47 OTHER MECHANICAL COMPLICATION OF PROSTHETIC JOINT IMPLANT

996.49 OTHER MECHANICAL COMPLICATION OF OTHER INTERNAL ORTHOPEDIC DEVICE, IMPLANT, AND GRAFT

996.62 INFECTION AND INFLAMMATORY REACTION DUE TO OTHER VASCULAR DEVICE IMPLANT AND GRAFT

996.90 -

996.94 opens in new window

COMPLICATIONS OF UNSPECIFIED REATTACHED EXTREMITY - COMPLICATIONS OF REATTACHED UPPER EXTREMITY OTHER AND UNSPECIFIED

999.2 OTHER VASCULAR COMPLICATIONS OF MEDICAL CARE NOT ELSEWHERE CLASSIFIED

999.31 -

999.39 opens in new window

OTHER AND UNSPECIFIED INFECTION DUE TO CENTRAL VENOUS CATHETER - INFECTION FOLLOWING OTHER INFUSION, INJECTION, TRANSFUSION, OR VACCINATION

V10.81 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF BONE V67.00 FOLLOW-UP EXAMINATION FOLLOWING UNSPECIFIED SURGERY V67.1 FOLLOW-UP EXAMINATION FOLLOWING RADIOTHERAPY

V67.2 FOLLOW-UP EXAMINATION FOLLOWING CHEMOTHERAPY

Diagnoses that Support Medical Necessity N/A

ICD-9 Codes that DO NOT Support Medical Necessity XX000 Not Applicable

ICD-9 Codes that DO NOT Support Medical Necessity Asterisk Explanation

Diagnoses that DO NOT Support Medical Necessity N/A

General Information

Documentations Requirements

The documentation of the study requires a formal written report, with clear identifying demographics, the name of the interpreting provider, reason for the test, and interpretive report and copies of all images obtained. The computerized data with image reconstruction should also be maintained.

The medical record must contain documentation, including a written or electronic request for the procedure which fully supports the medical necessity of the procedure performed. This documentation includes, but is not limited

to relevant medical history, physical examination, diagnosis (if known), pertinent signs and symptoms and results

of pertinent diagnostic tests and/or procedures. This entire documentation-not just the test report or the findings/diagnosis on the order, must be made available to Medicare upon request.

When a CT scan and MRI are performed on the same day for the same anatomical area, the medical record must clearly reflect the medical necessity for performing both tests.

Rules for Testing Facility to Furnish Additional Tests:

If the testing facility cannot reach the treating physician/practitioner to change the order or obtain a new order and documents this in the medical record, then the testing facility may furnish the additional diagnostic test if all of the following criteria apply:

• The testing center performs the diagnostic test ordered by the treating physician/practitioner;

• The interpreting physician at the testing facility determines and documents that, because of the abnormal result of the diagnostic test performed, an additional diagnostic test is medically necessary;

• Delaying the performance of the additional diagnostic test would have an adverse effect on the care of the beneficiary;

• The result of the test is communicated to and is used by the treating physician/practitioner in the treatment of the beneficiary; and

• The interpreting physician at the testing facility documents in his/her report why additional testing was done.

Rules for Testing Facility Interpreting Physician to Furnish Different or Additional Tests:

The following applies to an interpreting physician of a testing facility who furnishes a diagnostic test to a beneficiary who is not a hospital inpatient or outpatient. The interpreting physician must document accordingly in his/her report to the treating physician/practitioner.

Test Design:

Unless specified in the order, the interpreting physician may determine, without notifying the treating physician/practitioner, the parameters of the diagnostic test (e.g., number of radiographic views obtained, thickness or tomographic sections acquired, use or non-use of contrast media).

Appendices

Utilization Guidelines N/A

Sources of Information and Basis for Decision

American College of Radiology (2010). Practice guideline for communication of diagnostic imaging findings. Retrieved from http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines.aspx

American College of Radiology (2006). Practice guideline for performing and interpreting magnetic resonance imaging (MRI). Retrieved from http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines.aspx

American College of Radiology-Society of Skeletal Radiology (2007). Practice guideline for the performance of magnetic resonance imaging (MRI) of the wrist. Retrieved from http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines.aspx

American College of Radiology-Society of Skeletal Radiology (2010). Practice guideline for the performance and interpretation of magnetic resonance imaging (MRI) of the shoulder. Retrieved from http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines.aspx

American College of Radiology-Society of Skeletal Radiology (2006). Practice guideline for the performance and interpretation of magnetic resonance imaging (MRI) of the elbow. Retrieved from http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines.aspx

Goldman, L., & Bennett, C., (2000). Cecil Textbook of Medicine, (21st ed.). Philadelphia: W.B. Saunders. Source used to define further indications for intra-articular and periarticular soft tissue structures.

American College of Radiology. (2000). ACR Appropriateness CriteriaTM Radiology, 215 (Suppl), 107-112, 225-

229, 299-302, 333-338, 339-343, 375-378, 597-605, 1029-1040. Source used for indications and limitations.

Magnetic Resonance Imaging Clinics of North America. (May, 2004). MR Imaging of Tumors and tumor-like lesions of the upper extremity, 12(2): 349-59.

Primary Care: Clinics In Office Practice. (2004). Rotator cuff injuries and treatment, 31, 807-829.

Advisory Committee Meeting Notes This Local Coverage Determination (LCD) does not reflect the sole opinion of the contractor or Contractor Medical Director. Although the final decision rests with the contractor, this LCD was developed in cooperation with the advisory groups, which includes representatives from numerous societies.

Start Date of Comment Period

End Date of Comment Period

Start Date of Notice Period 05/01/2011

Revision History Number 5

Revision History Explanation Revision Number:5 Start Date of Comment Period:N/A

Start Date of Notice Period:10/01/2011 Revised Effective Date: 07/07/2011

LCR B2011-105

September 2011 Connection

Explanation of Revision: The Limitations section of the LCD has been revised to update language surrounding the coverage of MRI in patients with implantable pacemakers. CMS issued new language in the NCD for Pacemakers through Change Request 7441, transmittals 134 and 2293. These revisions are effective for claims processed on or after September 26, 2011 for dates of service on or after July 7, 2011.

Revision Number:4

Start Date of Comment Period:N/A Start Date of Notice Period:10/01/2011 Revised Effective Date:10/01/2011

LCR B2011-101

September 2011 Connection

Explanation of Revision: Annual 2012 ICD-9-CM Update. Added diagnosis code range 173.60-173.69. Changed individual diagnosis codes 999.31 and 999.39 to diagnosis code range 999.31-999.39, to include new diagnosis codes 999.32, 999.33, and 999.34. Deleted diagnosis code 173.6. The effective date of this revision is based on date of service.

Revision Number:3

Start Date of Comment Period:N/A Start Date of Notice Period:05/01/2011 Revised Effective Date: 02/24/2011

LCR B2011-054

April 2011 Update

Explanation of Revision: Under the “Documentation Requirements” section of the LCD, verbiage was updated to be in line with the guidelines used to develop the LCD. In addition, references were updated under the “Sources of Information and Basis for Decision” section of the LCD. The effective date of this LCD revision is based on date of service 04/05/2011. Under the “Indications and Limitations” section of the LCD, language was added according to instructions outlined in Change Request 7296, related to the National Coverage Determination (NCD) 220.2.Transmittal 132, dated 3/4/2011. Revisions related to CR 7296 will be effective for claims processed on or after April 4, 2011, for dates of service on or after 2/24/2011.

Revision Number:2

Start Date of Comment Period:N/A Start Date of Notice Period:10/01/2010 Revised Effective Date: 10/01/2010

LCR B2010-071

September 2010 Update

Explanation of Revision: Annual 2011 ICD-9-CM Update. Changed diagnosis code range to 237.70-237.79 to add diagnosis codes 237.73 and 237.79. Added new diagnosis code range 447.70-447.73. The effective date of this revision is based on date of service.

Revision Number:1

Start Date of Comment Period:N/A Start Date of Notice Period:10/01/2009 Revised Effective Date: 10/01/2009

LCR B2009-098

September 2009 Update

Explanation of Revision: Annual 2010 ICD-9-CM Update. Deleted diagnosis code 274.0. Added new diagnosis codes 274.00-274.03 and 359.71. Revised descriptors for diagnosis codes 793.7 and 996.43. The effective date of this revision is based on date of service

Revision Number:Original

Start Date of Comment Period:N/A Start Date of Notice Period:12/04/2008 Revised Effective Date:02/02/2009

LCR B2009-044FL

December 2008 Bulletin

This LCD consolidates and replaces all previous policies and publications on this subject by the carrier predecessors of First Coast Service Options, Inc. (Triple S and FCSO).

For Florida (00590) this LCD (L29223) replaces LCD L13838 as the policy in notice. This document (L29223) is effective on 02/02/2009.

08/08/2009 - This policy was updated by the ICD-9 2009-2010 Annual Update. 08/27/2011 - This policy was updated by the ICD-9 2011-2012 Annual Update.

Reason for Change